Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CITA Biomedical Retains Investor Relations Network as Its External Financial Public Relations Counsel.


Business Editors

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--June 7, 2000

CITA CITA Committee for the Implementation of Textile Agreements
CITA Canadian Institute for Theoretical Astrophysics
CITA Center for Information Technology Accommodation (US; now the GSA IT Accommodation Division) 
 Biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:DTOX), a growing leader in the treatment and rapid detoxification Detoxification Definition

Detoxification is one of the more widely used treatments and concepts in alternative medicine. It is based on the principle that illnesses can be caused by the accumulation of toxic substances (toxins) in the body.
 of persons addicted to opiate-based drugs, today announced that it has retained the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 Network (IRN IRN n abbr (= Independent Radio News) → servicio de noticias en las cadenas de radio privadas

IRN n abbr (= Independent Radio News) → agence de presse radiophonique

) as its external financial public relations Financial public relations

Public relations division of a company charged with cultivating positive investor relations and proper disclosure information.
 counsel.

"With the recent recommendation of our company's stock by Communications Capital Corp., CITA's management felt this was a prudent time to begin sharing with investors at every level our goals for the future," said President and Chief Executive Officer Joseph V. Dunn.

"We intend to grow this company rapidly and to maximize the return for our shareholders. As part of that process, we have retained the Investor Relations Network to better position us within the investment community.

"Moreover, as part of its commitment to the future of CITA Biomedical, the IRN has requested that a significant part of its compensation be in the form of restricted company stock it intends to hold for the longer term," Dunn continued.

Currently, CITA Biomedical is conducting its detoxification programs in five major metropolitan hospitals, located in Chicago; Los Angeles; Phoenix; Denver; and Portland, Ore. Over the next several years, that number is expected to triple, as the company plans to bring the procedure to an additional 10 hospitals.

The company also intends to expand its scope to treat most addictions, including drugs, behavioral and alcohol, and is researching a vaccine for cocaine. It also is exploring acquisition candidates. Further information on CITA Biomedical is available at www.citabio.com.

The Investor Relations Network is a full-service financial public relations partnership with headquarters in Costa Mesa, Calif., and additional offices in Irvine, Calif.; Los Angeles; New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
; and Dallas. It provides investor relations and corporate communications programs for publicly traded and pre-IPO firms nationwide. It also is currently assisting eight private as well as publicly held companies in securing nearly $100 million in interim financing.

This news release contains forward-looking statements regarding the company and its businesses. These forward-looking statements are based largely on the company's expectations and are subject to a number of risks and uncertainties, some of which are beyond the company's control. The company undertakes no obligation to publicly release the results of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 7, 2000
Words:398
Previous Article:Patent Allowance Gives STI Rights to Use Sertoli Cell Lines in Islet Transplantation, Cell-Based Gene Therapy.
Next Article:PacSun.com is First to Launch Pro Skateboarder Tony Hawk's Footwear Line.



Related Articles
Freedomstocks.com Announces Investment Opinions For Week Of February 28, 2000.
CITA Biomedical Appears On Alexander Haig's `World Business Review' TV Series.
RPT/CITA Biomedical Appears On Alexander Haig's `World Business Review' TV Series.
Communications Capital Corporation Announces Investment Opinion On CITA Biomedical.
CITA Biomedical Appears on Alexander Haig's ``World Business Review'' TV Series.
CITA Biomedical Launches Much Anticipated CubeCentral.com.
CITA Biomedical Receives Standard & Poor's Approval For Listing in Its Comprehensive Market Access Program.
CITA Biomedical Delivers Significant Enhancements to CubeCentral.com.
A new weapon in the war on drugs: corporation unveils a new treatment for substance abusers. (Newsmakers).
Four assume roles on AASA's governing board. (Executive Committee Newcomers).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles